Nigeria today stands at a dangerous national-security crossroads. Citizens confront an unrelenting mix of banditry, terrorism, ...

Parliament has replaced MGNREGA with a new bill, the Viksit Bharat-Guarantee for Rozgar and Ajeevika Mission (Gramin) Bill, ...

NEW YORK CITY, NY / ACCESS Newswire / December 23, 2025 / Cholame Finance Academy has released its Annual Digital Intelligence Report, a publication that documents how the organization reviews and ...

The study advances a broader argument about the future of responsible AI. It contends that ethical AI cannot be achieved ...

First Patient Dosed with Intranasal Foralumab in Randomized, Placebo-Controlled Phase 2 Trial Builds on Recent Evidence of Persistent ...

-- First Patient Expected to be Dosed Next Week with Intranasal Foralumab -- PET Scan Shows Presence of Untreated Neuroinflammation in Alzheimer's Patient on Leqembi (R) (Lecanemab) Anti-Amyloid ...

Amgen (NASDAQ:AMGN) today announced that the U.S. Food and Drug Administration (FDA) has approved UPLIZNA® (inebilizumab-cdon) for the treatment of generalized myasthenia gravis (gMG) in adults who ...

However, there is a distinct difference between a capable secondary machine and a daily driver that can handle the heat — literally. In most mini PCs, with the notable exception of Apple's ...

Despite decades of warnings, California judges continue to appoint unvetted attorneys as minors counsel and "parenting ...

Long-term property value depends on consistent care shaped by local conditions rather than quick fixes. Homes in Portland ...

Pharmacy benefit managers (PBMs) significantly impact GTN revenue through rebates, but patient access issues persist due to high out-of-pocket costs. Traditional market access practices are being ...